810 related items for PubMed ID: 29461447
1. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
3. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
4. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
Han CL, Zhao SL.
Med Sci Monit; 2018 Oct 11; 24():7264-7270. PubMed ID: 30307902
[Abstract] [Full Text] [Related]
5. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.
Miyata K, Bainto EV, Sun X, Jain S, Dummer KB, Burns JC, Tremoulet AH.
Arch Dis Child; 2023 Oct 11; 108(10):833-838. PubMed ID: 37258054
[Abstract] [Full Text] [Related]
6. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 11; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
7. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 11; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
8. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Mar 11; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
9. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
10. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
[Abstract] [Full Text] [Related]
11. Efficacy and safety of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis.
Wang L, He M, Wang W, Li S, Zhao G.
Eur J Pediatr; 2024 Apr 27; 183(4):1765-1776. PubMed ID: 38240765
[Abstract] [Full Text] [Related]
12. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Apr 27; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
13. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
[Abstract] [Full Text] [Related]
14. The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.
Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC, KIDCARE Multicenter Study Group, Anand V, Anderson M, Ang J, Ansusinha E, Arditi M, Ashouri N, Bartlett A, Chatterjee A, DeBiasi R, Dekker C, DeZure C, Didion L, Dominguez S, El Feghaly R, Erdem G, Halasa N, Harahsheh A, Jackson MA, Jaggi P, Jain S, Jone PN, Kaushik N, Kurio G, Lillian A, Lloyd D, Manaloor J, McNelis A, Michalik DE, Newburger J, Newcomer C, Perkins T, Portman M, Romero J, Ronis T, Rowley A, Schneider K, Schuster J, Tejtel SKS, Sharma K, Simonsen K, Szmuszkovicz J, Truong D, Wood J, Yeh S.
Contemp Clin Trials; 2019 Apr 01; 79():98-103. PubMed ID: 30840903
[Abstract] [Full Text] [Related]
15. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
Kaohsiung J Med Sci; 2012 Jan 01; 28(1):23-9. PubMed ID: 22226058
[Abstract] [Full Text] [Related]
16. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J, Liu P, Hu W, Xu Y, Deng J.
Clin Rheumatol; 2021 Oct 01; 40(10):4191-4197. PubMed ID: 34059986
[Abstract] [Full Text] [Related]
17. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
Chan H, Chi H, You H, Wang M, Zhang G, Yang H, Li Q.
BMC Pediatr; 2019 May 17; 19(1):158. PubMed ID: 31101091
[Abstract] [Full Text] [Related]
18. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
Turk J Pediatr; 2020 May 17; 62(1):1-9. PubMed ID: 32253860
[Abstract] [Full Text] [Related]
19. Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis.
Li X, Tang Y, Ding Y, Chen Y, Hou M, Sun L, Qian G, Qin L, Lv H.
Eur J Pharmacol; 2021 May 15; 899():173985. PubMed ID: 33652059
[Abstract] [Full Text] [Related]
20. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.
Eur J Pediatr; 2019 Mar 15; 178(3):315-322. PubMed ID: 30499051
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
